The European healthcare CDMO market is projected to grow at a significant CAGR during the forecast period. The increasing demand for innovations in drug development for better productivity in pharmaceutical production and reliable research is leading to outsourcing within the region.
Further, the increasing expenditure in the healthcare sector by European countries has also been observed. This is the major factor driving the growth of the European pharmaceutical contract manufacturing industry that propels the CDMO market. Additionally, contract manufacturing and research activities are pacing up to cater to the ever-increasing demands by the healthcare industry to provide advanced treatment options in Europe.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/europe-healthcare-cdmo-market
Moreover, the presence of global leader biotech companies including GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and other major biopharmaceutical companies in Europe makes it one of the leading markets in the global life science industry. The rise in R&D investment by these market players would significantly contribute to the growth of the European pharmaceuticals contract manufacturing market. AstraZeneca PLC has spent a large amount of fund of around $5.6 billion for R&D during 2016-2017.
Europe has made significant R&D in pharmaceuticals mainly due to the increasing drug discovery and research, and growing demand for innovative drugs. Additionally, the increasing investment of the government in the life sciences and biopharmaceuticals is further augmenting the growth of the market in the region.
Key Questions Addressed by the Report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and the coming years?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
A full report of European Healthcare CDMO Market is available at: https://www.omrglobal.com/industry-reports/europe-healthcare-cdmo-market
European healthcare CDMO Market – Segmentation
By Services
- Contract Development
o Clinical
o Preclinical
o Laboratory Services
- Contract Manufacturing
o Active Pharmaceutical Ingredients (API)
o Finish Dosage Formulations
o Medical Devices
European Healthcare CDMO Market – Segmentation by Region
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- AbbVie Inc.
- Almac Group Ltd.
- Braun Melsungen AG
- Boehringer Ingelheim International GmbH
- Jubilant Life Sciences Ltd.
- Lonza Group Ltd.
- Pfizer Inc.
- Probiogen AG
- Recipharm AB
- Siegfried Holding AG
- Thermo Fisher Scientific Inc.
